{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T06:59:34Z","timestamp":1787900374796,"version":"build-2784847793"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010969","name":"Alzheimer Nederland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010969","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008398","name":"Internationale Stichting Alzheimer Onderzoek","doi-asserted-by":"publisher","award":["#11519"],"award-info":[{"award-number":["#11519"]}],"id":[{"id":"10.13039\/501100008398","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.neurobiolaging.2019.01.015","type":"journal-article","created":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T02:13:51Z","timestamp":1548814431000},"page":"201.e9-201.e14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Genetic screening in early-onset Alzheimer's disease identified three novel presenilin mutations"],"prefix":"10.1016","volume":"86","author":[{"given":"Tsz Hang","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harro","family":"Seelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamiram","family":"Melhem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemieke J.M.","family":"Rozemuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"van Swieten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2019.01.015_bib1","doi-asserted-by":"crossref","first-page":"208.e211","DOI":"10.1016\/j.neurobiolaging.2015.09.016","article-title":"Pilot whole-exome sequencing of a German early-onset Alzheimer's disease cohort reveals a substantial frequency of PSEN2 variants","volume":"37","author":"Blauwendraat","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2019.01.015_bib2","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1080\/07853890802186905","article-title":"Molecular genetics of Alzheimer's disease: an update","volume":"40","author":"Brouwers","year":"2008","journal-title":"Ann. Med."},{"key":"10.1016\/j.neurobiolaging.2019.01.015_bib3","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1093\/hmg\/4.12.2373","article-title":"Mutations of the presenilin I gene in families with early-onset Alzheimer's disease","volume":"4","author":"Campion","year":"1995","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neurobiolaging.2019.01.015_bib4","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nm0498-452","article-title":"A\u00a0variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1","volume":"4","author":"Crook","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.neurobiolaging.2019.01.015_bib5","doi-asserted-by":"crossref","first-page":"e31039","DOI":"10.1371\/journal.pone.0031039","article-title":"Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer's disease families","volume":"7","author":"Cruchaga","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2019.01.015_bib6","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/humu.22117","article-title":"Locus-specific mutation databases for neurodegenerative brain diseases","volume":"33","author":"Cruts","year":"2012","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.neurobiolaging.2019.01.015_bib7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/hmg\/7.1.43","article-title":"Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease","volume":"7","author":"Cruts","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neurobiolaging.2019.01.015_bib8","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jalz.2014.05.1753","article-title":"Diagnostic impact of CSF biomarkers for Alzheimer's disease in a tertiary memory clinic","volume":"11","author":"Duits","year":"2015","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2019.01.015_bib9","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.neuroscience.2014.03.052","article-title":"Novel presenilin mutations within Moroccan patients with early-onset Alzheimer's disease","volume":"269","author":"El Kadmiri","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2019.01.015_bib10","doi-asserted-by":"crossref","first-page":"e1007045","DOI":"10.1371\/journal.pgen.1007045","article-title":"Analysis of neurodegenerative Mendelian genes in clinically diagnosed Alzheimer disease","volume":"13","author":"Fernandez","year":"2017","journal-title":"PLoS Genet."},{"key":"10.1016\/j.neurobiolaging.2019.01.015_bib11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.nbd.2016.06.004","article-title":"Next-generation sequencing reveals substantial genetic contribution to dementia with Lewy bodies","volume":"94","author":"Geiger","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2019.01.015_bib12","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/ng.3021","article-title":"Whole-genome sequence variation, population structure and demographic history of the Dutch population","volume":"46","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neurobiolaging.2019.01.015_bib13","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/349704a0","article-title":"Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease","volume":"349","author":"Goate","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2019.01.015_bib14","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1474-4422(17)30400-3","article-title":"Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study","volume":"17","author":"Guerreiro","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.01.015_bib15","series-title":"A\u00a0Comprehensive Assessment of Benign Genetic Variability for Neurodegenerative Disorders","author":"Guerreiro","year":"2018"},{"key":"10.1016\/j.neurobiolaging.2019.01.015_bib16","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.neurobiolaging.2008.06.012","article-title":"Genetic screening of Alzheimer's disease genes in Iberian and African samples yields novel mutations in presenilins and APP","volume":"31","author":"Guerreiro","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2019.01.015_bib17","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1750-3639.2000.tb00269.x","article-title":"Lewy bodies in Alzheimer's disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry","volume":"10","author":"Hamilton","year":"2000","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neurobiolaging.2019.01.015_bib18","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.1136\/jmg.39.2.e2","article-title":"Spastic paraparesis and atypical dementia caused by PSEN1 mutation (P264L), responsible for Alzheimer's disease","volume":"39","author":"Jacquemont","year":"2002","journal-title":"J.\u00a0Med. Genet."},{"issue":"Pt 4","key":"10.1016\/j.neurobiolaging.2019.01.015_bib19","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/brain\/awq033","article-title":"Alzheimer's disease phenotypes and genotypes associated with mutations in presenilin 2","volume":"133","author":"Jayadev","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2019.01.015_bib20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuron.2014.05.041","article-title":"Alzheimer's disease genetics: from the bench to the clinic","volume":"83","author":"Karch","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2019.01.015_bib21","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ng.2892","article-title":"A\u00a0general framework for estimating the relative pathogenicity of human genetic variants","volume":"46","author":"Kircher","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neurobiolaging.2019.01.015_bib22","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature19057","article-title":"Analysis of protein-coding genetic variation in 60,706 humans","volume":"536","author":"Lek","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2019.01.015_bib23","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/archneur.63.3.370","article-title":"Lewy body pathology in familial Alzheimer disease: evidence for disease- and mutation-specific pathologic phenotype","volume":"63","author":"Leverenz","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.01.015_bib24","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1006\/geno.1996.0266","article-title":"Genomic structure and expression of STM2, the chromosome 1 familial Alzheimer disease gene","volume":"34","author":"Levy-Lahad","year":"1996","journal-title":"Genomics"},{"key":"10.1016\/j.neurobiolaging.2019.01.015_bib25","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.neurobiolaging.2019.01.015_bib26","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0002-9440(10)65722-7","article-title":"Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes","volume":"153","author":"Lippa","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neurobiolaging.2019.01.015_bib27","doi-asserted-by":"crossref","first-page":"1850.e17","DOI":"10.1016\/j.neurobiolaging.2012.02.020","article-title":"Identification of PSEN1 and PSEN2 gene mutations and variants in Turkish dementia patients","volume":"33","author":"Lohmann","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2019.01.015_bib28","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0006-3223(02)01386-0","article-title":"Clinical and biomarker investigation of a patient with a novel presenilin-1 mutation (A431V) in the mild cognitive impairment stage of Alzheimer's disease","volume":"52","author":"Matsushita","year":"2002","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2019.01.015_bib29","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2019.01.015_bib30","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res."},{"key":"10.1016\/j.neurobiolaging.2019.01.015_bib31","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2019.01.015_bib32","doi-asserted-by":"crossref","first-page":"629.e5","DOI":"10.1016\/j.neurobiolaging.2011.10.014","article-title":"DLB and PDD: a role for mutations in dementia and Parkinson disease genes?","volume":"33","author":"Meeus","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2019.01.015_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","article-title":"National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach","volume":"123","author":"Montine","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2019.01.015_bib34","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1001\/jamaneurol.2013.1925","article-title":"A\u00a0multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies","volume":"70","author":"Nalls","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.01.015_bib35","doi-asserted-by":"crossref","first-page":"292.e7","DOI":"10.1016\/j.neurobiolaging.2018.04.015","article-title":"Genetic screening in early-onset dementia patients with unclear phenotype: relevance for clinical diagnosis","volume":"69","author":"Perrone","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2019.01.015_bib36","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1212\/01.wnl.0000310643.53587.87","article-title":"A\u00a0novel PSEN2 mutation associated with a peculiar phenotype","volume":"70","author":"Piscopo","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2019.01.015_bib37","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/519795","article-title":"PLINK: a tool set for whole-genome association and population-based linkage analyses","volume":"81","author":"Purcell","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neurobiolaging.2019.01.015_bib38","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/jnen\/nlv028","article-title":"Neuropathology of autosomal dominant Alzheimer disease in the national Alzheimer coordinating center database","volume":"75","author":"Ringman","year":"2016","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.01.015_bib39","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1212\/WNL.57.4.621","article-title":"Screening for PS1 mutations in a referral-based series of AD cases: 21 novel mutations","volume":"57","author":"Rogaeva","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2019.01.015_bib40","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/S1474-4422(16)30193-4","article-title":"Clinical phenotype and genetic associations in autosomal dominant familial Alzheimer's disease: a case series","volume":"15","author":"Ryan","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2019.01.015_bib41","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1212\/WNL.0000000000000596","article-title":"Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis","volume":"83","author":"Ryman","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2019.01.015_bib42","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jfma.2015.08.004","article-title":"A\u00a0systematic review of familial Alzheimer's disease: differences in presentation of clinical features among three mutated genes and potential ethnic differences","volume":"115","author":"Shea","year":"2016","journal-title":"J.\u00a0Formos. Med. Assoc."},{"key":"10.1016\/j.neurobiolaging.2019.01.015_bib43","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00401-009-0521-4","article-title":"Variations in the neuropathology of familial Alzheimer's disease","volume":"118","author":"Shepherd","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2019.01.015_bib44","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/375754a0","article-title":"Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease","volume":"375","author":"Sherrington","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2019.01.015_bib45","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/ejhg.2017.110","article-title":"Population-specific genetic variation in large sequencing data sets: why more data is still better","volume":"25","author":"van Rooij","year":"2017","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.neurobiolaging.2019.01.015_bib46","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neurobiolaging.2019.01.015_bib47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/alzrt107","article-title":"Molecular consequences of amyloid precursor protein and presenilin mutations causing autosomal-dominant Alzheimer's disease","volume":"4","author":"Weggen","year":"2012","journal-title":"Alzheimers Res. Ther."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458019300296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458019300296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:33:22Z","timestamp":1759318402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458019300296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":47,"alternative-id":["S0197458019300296"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2019.01.015","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic screening in early-onset Alzheimer's disease identified three novel presenilin mutations","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2019.01.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}